Inside the Briefcase

2016 APM Reference Guide: Application Performance Monitoring

2016 APM Reference Guide: Application Performance Monitoring

IT Briefcase Analyst Report
This product guide allows you to...

IT Briefcase Exclusive Interview: Top IoT Trends and Predictions for Organizations in 2016

IT Briefcase Exclusive Interview: Top IoT Trends and Predictions for Organizations in 2016

with Mike Martin, nfrastructure
In this interview, Mike Martin,...

Unleash the Power of Global Content

Unleash the Power of Global Content

globeYour business depends on pushing accurate and dynamic content...

Clicking Away Your Right to Privacy

Clicking Away Your Right to Privacy

Before using any standard Internet service provider for e-mail...

Top Questions to Ask Before Implementing VoIP

Top Questions to Ask Before Implementing VoIP

Thinking about a move away from traditional phone lines...

The Debate is Over: Changing the Conversation Around Concussion Diagnostics

August 27, 2013 No Comments

Featured blog by Chase Curtiss, CEO, Sway Medical

The Cleveland Clinic today launched an expansion of their iPad-based concussion testing platform to rural communities in Iowa as highlighted by a recent mobihealthnews article.  The Cleveland Clinic has been working on building this technology for the past 18 to 24 months and it is exciting to see that an institution such as the Cleveland Clinic is taking such an interest in mobile concussion diagnostics.  Currently the Cleveland Clinic technology is working through the logistics of distribution and has not yet launched to the public for sale.  The C3 Logix app is still being tested in Cleveland area schools and now in a rural area Iowa high school inventor Jay Alberts commented.

The C3 technology is interesting and brings up the debate over the need for Food and Drug Administration (FDA) clearance with mobile-based medial diagnostics.  The concussion industry has traditionally shied away from the FDA and avoided terms like diagnostic or medical device even though in a traditional sense this is exactly what concussion assessment tools are.  It will be interesting to see if the C3 has taken the route of being a medical device developed with an appropriate quality system and meeting the standards of the FDA.  It appears that their delay in launch is likely an effort to continue beta testing and while deciding on whether to submit an application to the FDA.

This decision was the center of Sway Medical’s culture moving forward.  As the Founder and CEO of the company, it was imperative that we transition the conversation of concussions as “dings, stingers, bell ringing” into categorizing them as a true medical condition necessitating review by the agencies that regulate medical devices and by qualified medical professionals.

The FDA guidelines on mobile devices state that:

“Apps that use a mobile platform to record response time and accuracy of patients completing a cognitive task and/or automatically score or interpret cognitive testing results”

and

“Apps that use the built-in accelerometer or other similar sensors in a mobile platform to monitor the user’s movement to determine conditions such as sleep apnea, sleep phase, fall detection, or detect motion related to other conditions or diseases or to measure heart rate”

In order to drive acceptance of mobile as medical instead of as pseudo-medical or wellness, it is important to commit to the same standards and regulations that every other medical device is held to.

Modernizing the healthcare system through the advancement of analytics and technology can only be done with a commitment to quality standards and avoiding the lure of revenue before regulatory validation.

 

Blogs, Featured Blogs, HEALTH IT

Leave a Reply

(required)

(required)


ADVERTISEMENT

AnDevCon


American Customer Festival 2016 New York

ITBriefcase Comparison Report

Cyber Security Exchange